3 Broken Breakers Worth Buying

In this episode of Motley Fool Money, Tim Beyers hosts Rick Munarriz and Karl Thiel to discuss "broken breakers," or Rule Breaker stocks that have stumbled but still hold long-term potential. They analyze the impact of federal layoffs on the biotech industry, particularly regarding the FDA and NIH. The hosts then delve into specific stock picks: The Trade Desk, Bristol Myers Squibb, and Progeny, examining the challenges and opportunities each company faces. The episode concludes with a round of "Yes And," an improv-style game involving bullish statements and concerns about Rule Breaker stocks: Arginix, Celsius, and Salesforce.